Update on sleep and its disorders

Annual Review of Medicine

Volumn 62, Issue , 2011, Pages 447-460

  Pack, Allan I ^a   Pien, Grace W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cardiovascular disease; diabetes; insulin resistance; narcolepsy; obstructive sleep apnea; restless legs syndrome; sleep deprivation

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HUMAN; INCREASED APPETITE; INSULIN RESISTANCE; INSULIN SENSITIVITY; NARCOLEPSY; NONHUMAN; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REM SLEEP; RESTLESS LEGS SYNDROME; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLOW WAVE SLEEP;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; HUMANS; INSULIN RESISTANCE; MALE; MICE; OBESITY; OXIDATIVE STRESS; PREGNANCY; SLEEP; SLEEP DISORDERS;

EID: 79551586006     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-med-050409-104056     Document Type: Article

References (90)

1. Colten HR, Altevogt BM. 2006. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: Natl. Acad. Press
2. Manolio TA, Collins FS, Cox NJ, et al. 2009. Finding the missing heritability of complex diseases. Nature 461:747-53
3. Kathiresan S, Willer CJ, Peloso GM, et al. 2009. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41:56-65
4. Lusis AJ, Pajukanta P. 2008. A treasure trove for lipoprotein biology. Nat. Genet. 40:129-30
5. Pearson TA, Manolio TA. 2008. How to interpret a genome-wide association study. JAMA. 299: 1335-44
6. Hindorff LA, Junkins HA, Hall PN, et al. 2010. A Catalog of Published Genome-Wide Association Studies. Available at http://www.genome.gov/gwastudies. Accessed Oct. 17, 2010
7. Allen RP, Walters AS, Montplaisir J, et al. 2005. Restless legs syndrome prevalence and impact: REST general population study. Arch. Intern. Med. 165:1286-92
8. Stefansson H, Rye DB, Hicks A, et al. 2007. A genetic risk factor for periodic limb movements in sleep. N. Engl. J. Med. 357:639-47
9. Trenkwalder C, Hogl B, Winkelmann J. 2009. Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. J. Neurol. 256:539-53
10. Allen R. 2004. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 5:385-91
11. Altmuller J, Palmer LJ, Fischer G, et al. 2001. Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet. 69:936-50
12. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-56
13. Winkelmann J, Schormair B, Lichtner P, et al. 2007. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat. Genet. 39:1000-6
14. Vilarino-Guell C, Farrer MJ, Lin SC. 2008. A genetic risk factor for periodic limb movements in sleep [comment]. N. Engl. J. Med. 358:425-27
15. Kemlink D, Polo O, Frauscher B, et al. 2009. Replication of restless legs syndrome loci in three European populations. J. Med. Genet. 46:315-18
16. Woloshin S, Schwartz LM. 2006. Giving legs to restless legs: a case study of how the media helps make people sick. PLoS Med. 3:e170
17. Vilarino-Guell C, Chai H, Keeling BH, et al. 2009. MEIS1 p.R272H in familial restless legs syndrome. Neurology 73:243-45
18. Xiong L, Catoire H, Dion P, et al. 2009. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum. Mol. Genet. 18:1065-74
19. Dasen JS, Tice BC, Brenner-Morton S, et al. 2005. A Hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 123:477-91
20. Gross MK, Dottori M, Goulding M. 2002. Lbx1 specifies somatosensory association interneurons in the dorsal spinal cord. Neuron 34:535-49
21. Zimmerman JE, Naidoo N, Raizen DM, et al. 2008. Conservation of sleep: insights from non-mammalian model systems. Trends Neurosci. 31:371-76
22. Schormair B, Kemlink D, Roeske D, et al. 2008. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat. Genet. 40:946-48
23. Uetani N, Chagnon MJ, Kennedy TE, et al. 2006. Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J. Neurosci. 26:5872-80
24. Mignot E. 2004. Sleep, sleep disorders and hypocretin (orexin). Sleep Med. 5(Suppl. 1):S2-8
25. Chabas D, Taheri S, Renier C, et al. 2003. The genetics of narcolepsy. Annu. Rev. Genomics Hum. Genet. 4:459-83
26. Lin L, Faraco J, Li R, et al. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-76
27. Chemelli RM, Willie JT, Sinton CM, et al. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-51
28. Mignot E, Lammers GJ, Ripley B, et al. 2002. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 59:1553-62
29. Thannickal TC, Moore RY, Nienhuis R, et al. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-74
30. Hallmayer J, Faraco J, Lin L, et al. 2009. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41:708-11
31. Jones CR, Campbell SS, Zone SE, et al. 1999. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat. Med. 5:1062-65
32. Takahashi JS. 2004. Finding new clock components: past and future. J. Biol. Rhythms 19:339-47
33. Toh KL, Jones CR, He Y, et al. 2001. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291:1040-43
34. Xu Y, Padiath QS, Shapiro RE, et al. 2005. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434:640-44
35. Xu Y, Toh KL, Jones CR, et al. 2007. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 128:59-70
36. He Y, Jones CR, Fujiki N, et al. 2009. The transcriptional repressor DEC2 regulates sleep length in mammals. Science 325:866-70
37. Young T, Palta M, Dempsey J, et al. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 328:1230-35
38. Pack AI, Gislason T. 2009. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog. Cardiovasc. Dis. 51:434-51
39. Lavie L. 2003. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med. Rev. 7:35-51
40. Arnardottir ES, Mackiewicz M, Gislason T, et al. 2009. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32:447-70
41. Savransky V, Nanayakkara A, Li J, et al. 2007. Chronic intermittent hypoxia induces atherosclerosis. Am. J. Respir. Crit. Care Med. 175:1290-97
42. Lee SA, Amis TC, Byth K, et al. 2008. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 31:1207-13
43. Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. 2008. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J. Am. Coll. Cardiol. 52:343-46
44. Marin JM, Carrizo SJ, Vicente E, et al. 2005. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-53
45. Villar I, Izuel M, Carrizo S, et al. 2009. Medication adherence and persistence in severe obstructive sleep apnea. Sleep 32:623-28
46. Romero-Corral A, Montori VM, Somers VK, et al. 2006. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666-78
47. Scheen AJ, Byrne MM, Plat L, et al. 1996. Relationships between sleep quality and glucose regulation in normal humans. Am. J. Physiol. 271:E261-70
48. Maquet P. 2000. Functional neuroimaging of normal human sleep by positron emission tomography. J. Sleep Res. 9:207-31
49. Nofzinger EA, Buysse DJ, Miewald JM, et al. 2002. Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain 125:1105-15
50. Thomas M, Sing H, Belenky G, et al. 2000. Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J. Sleep Res. 9:335-52
51. Knutson KL, Spiegel K, Penev P, et al. 2007. The metabolic consequences of sleep deprivation. Sleep Med. Rev. 11:163-78
52. Spiegel K, Leproult R, Colecchia EF, et al. 2000. Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:R874-83
53. Spiegel K, Leproult R, Van Cauter E. 1999. Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435-39
54. Vgontzas AN, Zoumakis E, Bixler EO, et al. 2004. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 89:2119-26
55. Spiegel K, Leproult R, L'Hermite-Baleriaux M, et al. 2004. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J. Clin. Endocrinol. Metab. 89:5762-71
56. Ayas NT, White DP, Al-Delaimy WK, et al. 2003. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26:380-84
57. Yaggi HK, Araujo AB, McKinlay JB, et al. 2006. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29:657-61
58. Kawakami N, Takatsuka N, Shimizu H, et al. 2004. Sleep disturbance and onset of type 2 diabetes. Diabetes Care 27:282-83
59. Mallon L, Broman JE, Hetta J, et al. 2005. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 28:2762-67
60. Meisinger C, Heier M, Loewel H, et al. 2005. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 48:235-41
61. Nilsson PM, Roost M, Engstrom G, et al. 2004. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 27:2464-69
62. Spiegel K, Tasali E, Penev P, et al. 2004. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann. Intern. Med. 141:846-50
63. Killgore WD, Kahn-Greene ET, Lipizzi EL, et al. 2008. Sleep deprivation reduces perceived emotional intelligence and constructive thinking skills. Sleep Med. 9:517-26
64. Nedeltcheva AV, Kilkus JM, Imperial J, et al. 2009. Sleep curtailment is accompanied by increased intake of calories from snacks. Am. J. Clin. Nutr. 89:126-33
65. Hasler G, Buysse DJ, Klaghofer R, et al. 2004. The association between short sleep duration and obesity in young adults: a 13-year prospective study. Sleep 27:661-66
66. Patel SR, Malhotra A, White DP, et al. 2006. Association between reduced sleep and weight gain in women. Am. J. Epidemiol. 164:947-54
67. Gangwisch JE, Malaspina D, Boden-Albala B, et al. 2005. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep 28:1289-96
68. Tasali E, Leproult R, Ehrmann DA, et al. 2008. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. USA 105:1044-49
69. Rao MN, Blackwell T, Redline S, et al. 2009. Association between sleep architecture and measures of body composition. Sleep 32:483-90
70. Pallayova M, Donic V, Gresova S, et al. 2010. Do differences in sleep architecture exist between persons with type 2 diabetes and nondiabetic controls? J. Diabetes Sci. Technol. 4:344-52
71. Lavie L. 2009. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog. Cardiovasc. Dis. 51:303-12
72. Iiyori N, Alonso LC, Li J, et al. 2007. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am. J. Respir. Crit. Care Med. 175:851-57
73. Polotsky VY, Li J, Punjabi NM, et al. 2003. Intermittent hypoxia increases insulin resistance in genetically obese mice. J. Physiol. (Lond.) 552:253-64
74. Punjabi NM, Sorkin JD, Katzel LI, et al. 2002. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care Med. 165:677-82
75. Punjabi NM, Shahar E,Redline S, etal. 2004. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol. 160:521-30
76. Tasali E, Mokhlesi B, Van Cauter E. 2008. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133:496-506
77. Meslier N, Gagnadoux F, Giraud P, et al. 2003. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur. Respir. J. 22:156-60
78. Makino S, Handa H, Suzukawa K, et al. 2006. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin. Endocrinol. (Oxf.) 64:12-19
79. Al-Delaimy WK, Manson JE, Willett WC, et al. 2002. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am. J. Epidemiol. 155:387-93
80. Elmasry A, Janson C, Lindberg E, et al. 2000. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J. Intern. Med. 248:13-20
81. Harsch IA, Schahin SP, Radespiel-Troger M, et al. 2004. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 169:156-62
82. Harsch IA, Schahin SP, BrucknerK,etal. 2004. The effectofcontinuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71:252-59
83. Babu AR, Herdegen J, Fogelfeld L, et al. 2005. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med. 165:447-52
84. Hassaballa HA, Tulaimat A, Herdegen JJ, et al. 2005. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breathing 9:176-80
85. Coughlin SR, Mawdsley L, Mugarza JA, et al. 2007. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur. Respir. J. 29:720-27
86. West SD, Nicoll DJ, Wallace TM, et al. 2007. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969-74
87. Facco FL, Grobman WA, Kramer J, et al. 2010. Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolism. Am. J. Obstet. Gynecol. 203:142e1-5
88. Qiu C, Enquobahrie D, Frederick IO, et al. 2010. Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study. BMC Women's Health 10:17
89. McCarthy MI, Abecasis GR, Cardon LR, et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9:356-69
90. Pack AI. 2006. Advances in sleep-disordered breathing. Am. J. Respir. Crit. Care Med. 173:7-15